A detailed history of Anchor Investment Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Anchor Investment Management, LLC holds 6,078 shares of AMGN stock, worth $1.61 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
6,078
Previous 6,211 2.14%
Holding current value
$1.61 Million
Previous $1.94 Billion 0.92%
% of portfolio
0.18%
Previous 0.2%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 21, 2024

SELL
$309.38 - $337.38 $41,147 - $44,871
-133 Reduced 2.14%
6,078 $1.96 Billion
Q2 2024

Sep 20, 2024

BUY
$262.75 - $319.31 $49,134 - $59,710
187 Added 3.1%
6,211 $1.94 Billion
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $246,822 - $297,946
918 Added 17.98%
6,024 $1.71 Billion
Q4 2023

Jan 02, 2024

BUY
$255.7 - $288.46 $1.31 Million - $1.47 Million
5,106 New
5,106 $1.47 Billion
Q3 2023

Jan 02, 2024

SELL
$218.65 - $271.46 $35,639 - $44,247
-163 Reduced 2.99%
5,294 $1.42 Billion
Q2 2023

Jan 02, 2024

SELL
$214.27 - $253.37 $61,924 - $73,223
-289 Reduced 5.03%
5,457 $1.21 Billion
Q1 2023

Jan 02, 2024

SELL
$225.79 - $275.2 $205,694 - $250,707
-911 Reduced 13.68%
5,746 $1.39 Billion
Q4 2022

Jan 02, 2024

BUY
$229.03 - $291.01 $355,225 - $451,356
1,551 Added 30.38%
6,657 $1.75 Billion
Q3 2022

Jan 02, 2024

BUY
$224.46 - $253.15 $200,442 - $226,062
893 Added 17.49%
5,999 $1.35 Billion
Q2 2022

Jan 02, 2024

SELL
$230.71 - $256.74 $62,060 - $69,063
-269 Reduced 4.27%
6,026 $1.47 Billion
Q1 2022

Jan 02, 2024

BUY
$219.27 - $242.57 $1,973 - $2,183
9 Added 0.14%
6,295 $1.52 Billion
Q4 2021

Jan 02, 2024

SELL
$198.88 - $227.6 $161,689 - $185,038
-813 Reduced 11.45%
6,286 $1.41 Billion
Q3 2021

Jan 02, 2024

BUY
$212.27 - $248.7 $423,054 - $495,659
1,993 Added 39.03%
7,099 $1.51 Billion
Q2 2021

Jan 02, 2024

SELL
$233.58 - $259.14 $52,555 - $58,306
-225 Reduced 2.65%
8,266 $2.01 Billion
Q1 2021

Jan 02, 2024

BUY
$221.91 - $258.6 $333,974 - $389,193
1,505 Added 21.54%
8,491 $2.11 Billion
Q4 2020

Jan 02, 2024

SELL
$216.38 - $257.67 $5,625 - $6,699
-26 Reduced 0.37%
6,986 $1.61 Billion
Q3 2020

Jan 02, 2024

BUY
$234.65 - $260.95 $447,242 - $497,370
1,906 Added 37.33%
7,012 $1.78 Billion
Q2 2020

Jan 02, 2024

BUY
$197.81 - $242.74 $24,726 - $30,342
125 Added 1.83%
6,968 $1.64 Billion
Q1 2020

Jan 02, 2024

BUY
$182.24 - $241.7 $34,625 - $45,923
190 Added 2.86%
6,843 $1.39 Billion
Q4 2019

Jan 02, 2024

SELL
$189.21 - $243.2 $10,406 - $13,376
-55 Reduced 0.82%
6,653 $1.6 Billion
Q3 2019

Jan 02, 2024

BUY
$174.11 - $208.62 $278,924 - $334,209
1,602 Added 31.37%
6,708 $1.3 Billion
Q2 2019

Jan 02, 2024

SELL
$166.7 - $195.41 $41,675 - $48,852
-250 Reduced 3.59%
6,708 $1.24 Billion
Q1 2019

Jan 02, 2024

SELL
$180.87 - $203.88 $83,381 - $93,988
-461 Reduced 6.21%
6,958 $1.32 Billion
Q4 2018

Jan 02, 2024

BUY
$178.4 - $208.25 $24,084 - $28,113
135 Added 1.85%
7,419 $1.44 Billion
Q3 2018

Jan 02, 2024

BUY
$185.29 - $208.89 $403,561 - $454,962
2,178 Added 42.66%
7,284 $1.51 Billion
Q2 2018

Jan 03, 2024

BUY
$166.05 - $186.51 $327,284 - $367,611
1,971 Added 38.6%
7,077 $1.31 Billion
Q1 2018

Jan 03, 2024

BUY
$169.43 - $198.0 $11,012 - $12,870
65 Added 0.94%
6,958 $1.19 Billion
Q4 2017

Jan 03, 2024

SELL
$168.79 - $188.59 $86,926 - $97,123
-515 Reduced 6.95%
6,893 $1.2 Billion
Q3 2017

Jan 03, 2024

BUY
$167.29 - $191.0 $4,182 - $4,775
25 Added 0.34%
7,408 $1.38 Billion
Q2 2017

Jan 03, 2024

BUY
N/A
2,277 Added 44.59%
7,383 $1.27 Billion
Q1 2017

Jan 03, 2024

BUY
N/A
1,933 Added 35.27%
7,413 $1.22 Billion
Q4 2016

Jan 03, 2024

BUY
N/A
647 Added 13.39%
5,480 $801 Million
Q3 2016

Jan 03, 2024

BUY
N/A
160 Added 3.42%
4,833 $806 Million
Q2 2016

Jan 03, 2024

SELL
N/A
-433 Reduced 8.48%
4,673 $711 Million
Q1 2016

Jan 03, 2024

SELL
N/A
-413
4,693 $704 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Anchor Investment Management, LLC Portfolio

Follow Anchor Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anchor Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anchor Investment Management, LLC with notifications on news.